在慢性阻塞性肺病患者中与代谢功能障碍相关的脂肪肝疾病:越南的见解
Doan Le Minh Hanh1, Le Thuong Vu2, Tran Le Doan Hanh3
1Internal Medicine Department, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 在COPD患者中很常见,肺功能恶化和恶化加剧. 这种情况是COPD恶化的一个独立风险因素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 影响了全球近一半的人口.
- MAFLD可以发展为严重的肝脏疾病,如肝硬化和肝细胞癌.
- 慢性阻塞性肺病 (COPD) 是一种主要的呼吸系统疾病,具有重大的全球影响.
研究的目的:
- 确定越南COPD患者中MAFLD的患病率和特征.
- 调查MAFLD和COPD恶化频率之间的关联.
- 为了确定患有MAFLD的COPD患者恶化的风险因素.
主要方法:
- 在越南,对稳定的COPD患者进行了一项横截面描述性研究.
- 纤维扫描用于诊断脂肪肝,MAFLD诊断基于2020年亚太地区肝脏研究协会的标准.
- 评估了肺功能和恶化病史.
主要成果:
- 在168名COPD患者中,48.8%患有MAFLD,与非MAFLD患者相比,肺功能较差 (FEV1,FVC).
- 在MAFLD组报告了更高的恶化频率 (≥2在过去的一年:46.3%对比30.2%).
- 较高的CAP分数 (>289dB/m) 和MAFLD是导致恶化的独立危险因素 (OR 5.64,p=0.001;OR 3.64,p=0.014).
结论:
- MAFLD在COPD患者中普遍存在,并与肺功能下降有关.
- MAFLD是一种独立的风险因素,与COPD恶化频率更高有关.
- 控制减弱参数 (CAP) 评分可以预测MAFLD患者的COPD恶化风险.
更多相关视频
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
